Halozyme Therapeutics, Inc Earning Date (HALO)

USA |NASDAQ |USD

HALO Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 8, 2022 Jun 2022 $0.58 - $0.66
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 8, 2022 Jun 2022 $143.11M - $136.46M

Halozyme Therapeutics, Inc's next earnings date is Monday, Aug 8, 2022 for the fiscal quarter ending Jun 2022.

HALO Earnings Date & History Chart

HALO Earnings & Revenue Forecast

HALO Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jun 2022 7 $0.58 $0.49 $0.77
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 10 $2.18 $2.06 $2.42
Dec 2023 8 $2.80 $2.12 $3.23

HALO Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Jun 2022 1 / 0 $0.54 $0.59 $0.75
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 1 / 0 $2.16 $2.22 $2.68
Dec 2023 1 / 0 $2.80 $2.86 $3.28

HALO Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Jun 2022 8 $143.11M $131.12M $177.20M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 11 $553.27M $540.85M $590.60M
Dec 2023 9 $671.96M $563.90M $756.58M

HALO Earnings Date & Revenue History

HALO Earnings History

|
Show More
Show More

HALO Revenue History

|
Show More
Show More

Halozyme Therapeutics, Inc Next Earnings Date & Report

HALO Next Earnings Date & Report Preview: Jun 2022 (FQ)

HALO's next earnings date is Monday, Aug 8, 2022 for the fiscal quarter ending Jun 30, 2022.

According to analysts, the average EPS estimation for Halozyme Therapeutics, Inc's next quarterly earnings is $0.58, with a low EPS estimation of $0.49, and a high estimation of $0.77.

Over the last 1 month, EPS estimates have seen 1 upward revisions and 0 downward. The EPS 1 month trend is $0.54, the last 2 month trend is $0.59, and the 3 month trend is $0.75.

Based on analysts, the average revenue estimation is $143.11M, with a low revenue estimation of $131.12M, and a high estimation of $177.20M.

Halozyme Therapeutics, Inc Previous Earnings Dates & Reports

HALO Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Halozyme Therapeutics, Inc's previous earnings date was May 9, 2022 for its fiscal quarter ended Mar 31, 2022.

HALO Previous Earnings Date & Report Recap: Dec 2021 (FY)

Halozyme Therapeutics, Inc's previous annual earnings date was Feb 22, 2022 for its fiscal year ended Dec 31, 2021.

HALO's earnings per share (EPS) was $2.00, beating the consensus analysts forecast of $1.97 by 1.52% , and higher than the previous year's EPS (Dec 2020) by 122.22%.

Revenues were $443.31M, better than the forecast of $441.33M by 0.45%, and up by 65.67% from previous year's revenue.

The company reported a net income of $402.71M, 211.97% higher than the previous year.

Halozyme Therapeutics, Inc reported a free cash flow of $297.98M for its fiscal year, compared to $52.95M a year ago.

The company ended the fiscal year with $876.67M in total debt, an increase of 120.70% compared to the previous year.